Research location
Oakville
Ontario, Canada
Advertisement
Research activity in Oakville
Ontario, CanadaCureCurrent currently publishes aggregate city-level research activity for this location: 166 trials and 173 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Oakville
166 linked trials · page 3 of 4Treatment of Type 2 Diabetes With Linagliptin 2.5 mg Bid + Metformin 500 or 1000 mg Bid and Metformin 1000 mg BidNCT00915772 · 2009-06-01 · 1 site observation
COMPLETED
ARI103094-Follow-Up Study for REDUCE Study SubjectsNCT00883909 · 2009-04-09 · 1 site observation
COMPLETED
Extension Study to Evaluate Long Term Safety of Denosumab in Subjects Undergoing ADT for Non-Metastatic Prostate CancerNCT00838201 · 2009-02-01 · 1 site observation
COMPLETED
Safety Study of the Inhibition of Agouti-related Protein (AgRP) for the Management of Obesity and Weight LossNCT00779519 · 2009-02-01 · 1 site observation
COMPLETED
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin MonotherapyNCT00823992 · 2009-01-01 · 1 site observation
COMPLETED
Safety and Efficacy of Linagliptin (BI 1356) Plus Metformin in Type 2 Diabetes, Factorial DesignNCT00798161 · 2008-12-01 · 1 site observation
COMPLETED
Canadian Study of Trandolapril on Blood Pressure in Hypertensive PatientsNCT01078584 · 2008-12-01 · 2 site observations
COMPLETED
A Study of LY2189265 Compared to Sitagliptin in Participants With Type 2 Diabetes Mellitus on MetforminNCT00734474 · 2008-08-01 · 1 site observation
COMPLETED
Safety and Efficacy of Linagliptin (BI 1356) as Monotherapy or in Combination in Type 2 DMNCT00736099 · 2008-08-01 · 1 site observation
COMPLETED
Follow-Up Study for ExuberaNCT00734591 · 2008-08-01 · 1 site observation
COMPLETED
Trial of Otelixizumab for Adults With Newly Diagnosed Type 1 Diabetes Mellitus (Autoimmune): DEFEND-1NCT00678886 · 2008-07-29 · 1 site observation
COMPLETED
Efficacy and Safety of Dapagliflozin, Added to Therapy of Patients With Type 2 Diabetes With Inadequate Glycemic Control on InsulinNCT00673231 · 2008-04-01 · 1 site observation
COMPLETED
A Phase IIa Proof-of-concept Study of NC-503 in Patients With Type II DiabetesNCT00675857 · 2008-04-01 · 1 site observation
COMPLETED
Study Evaluating the Clinical Benefit of SEROQUEL XR in Subjects With SchizophreniaNCT00640601 · 2008-03-01 · 1 site observation
COMPLETED
BI 1356 (Linagliptin) in Combination With Metformin and a Sulphonylurea in Type 2 DiabetesNCT00602472 · 2008-02-01 · 1 site observation
COMPLETED
A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) in Non-metastatic Hormone Resistant Prostate CancerNCT00626548 · 2008-01-01 · 1 site observation
TERMINATED
A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) in Hormone Resistant Prostate Cancer With Bone MetastasesNCT00554229 · 2007-11-01 · 1 site observation
COMPLETED
Distribution of Risk Factors in Ocular Hypertension and Open-Angle Glaucoma Patients in CanadaNCT00334750 · 2007-11-01 · 2 site observations
COMPLETED
Aliskiren Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease Endpoints (Core and Extension Phases)NCT00549757 · 2007-10-01 · 1 site observation
TERMINATED
A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled With Diet and ExerciseNCT00528372 · 2007-09-01 · 1 site observation
COMPLETED
Bone Health Observational StudyNCT00632905 · 2007-09-01 · 1 site observation
COMPLETED
Dose-Ranging Study In Subjects With Type 2 Diabetes Mellitus Who Are Treatment-NaiveNCT00495469 · 2007-08-17 · 1 site observation
COMPLETED
A Randomized, Double-blind, Two-arm Study Comparing the Efficacy and Safety of Trazodone Contramid® OAD and Placebo in the Treatment of Unipolar Major Depressive Disorder.NCT00775203 · 2007-06-01 · 1 site observation
COMPLETED
A 2-Month Safety Follow-Up TrialNCT00741429 · 2007-05-01 · 1 site observation
COMPLETED
Prostate Cancer Study In Men Who Have Failed First-Line Androgen Deprivation TherapyNCT00470834 · 2007-05-01 · 1 site observation
COMPLETED
A Long-term Extension Study Evaluating a One-Month Dosing Regimen of Degarelix in Prostate Cancer Requiring Androgen Ablation TherapyNCT00451958 · 2007-03-01 · 1 site observation
COMPLETED
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid ArthritisNCT00413699 · 2007-02-05 · 1 site observation
COMPLETED
Efficacy Study of Risedronate to Prevent Cancer Treatment-Induced Bone Loss in Prostate CancerNCT00426777 · 2007-01-01 · 1 site observation
COMPLETED
A Long-Term Study To Examine The Effects Of CP-945,598 On Weight Loss And SafetyNCT00375401 · 2006-10-01 · 1 site observation
TERMINATED
Assessment Of Dutasteride (AVODART) In Extending The Time To Progression Of Low-Risk, Localized Prostate Cancer In MenNCT00363311 · 2006-07-01 · 1 site observation
COMPLETED
Efficacy and Safety of 3 Doses of BI1356 (Linagliptin) in Type 2 Diabetes PatientsNCT00328172 · 2006-05-01 · 1 site observation
COMPLETED
Efficacy of Seroquel SR in Combination With an Antidepressant in Treatment of Major Depressive DisorderNCT00351169 · 2006-05-01 · 1 site observation
COMPLETED
Efficacy and Safety in Subjects With Type 2 Diabetes Receiving Subcutaneous Basal Insulin and Prandial Inhalation of Technosphere/Insulin Versus Subcutaneous Premixed Insulin Therapy Over a 52-Week Treatment Period and a 4-Week Follow-upNCT00309244 · 2006-02-01 · 1 site observation
COMPLETED
Efficacy & Safety of Inhaled Insulin in Type 1 DiabetesNCT00308308 · 2006-02-01 · 1 site observation
COMPLETED
Prospective Evaluation of Proteinuria and Renal Function in Non-diabetic Patients With Progressive Renal DiseaseNCT00296400 · 2006-02-01 · 1 site observation
COMPLETED
6-Month Safety And Efficacy Study Of TTP488 In Patients With Type 2 Diabetes And Persistent AlbuminuriaNCT00287183 · 2006-02-01 · 1 site observation
COMPLETED
Study Assessing Saxagliptin Treatment In Type 2 Diabetic Subjects Who Are Not Controlled With Metformin AloneNCT00121667 · 2005-08-01 · 1 site observation
COMPLETED
Saxagliptin Treatment in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and ExerciseNCT00121641 · 2005-07-01 · 1 site observation
COMPLETED
A 12-Week, Randomized, Double-Masked, Parallel Group Comparison Of Evening Dosing With Xalacom In Subjects With GlaucomaNCT00159653 · 2005-07-01 · 1 site observation
COMPLETED
A Clinical Trial to Study DR-2031 for the Treatment of Hot Flashes in Prostate Cancer PatientsNCT00196339 · 2005-06-01 · 1 site observation
COMPLETED
A Clinical Trial Assessing the Impact of the Availability of Inhaled Insulin on Glucose ControlNCT00134147 · 2005-04-01 · 1 site observation
COMPLETED
Extension Study Investigating the Long-Term Safety of Degarelix One-Month Depots in Patients With Prostate CancerNCT00117286 · 2005-03-01 · 1 site observation
COMPLETED
Prostate Cancer Prevention Study for Men With High Grade PIN (Prostatic Intraepithelial Neoplasia)NCT00106691 · 2005-01-01 · 1 site observation
COMPLETED
A Comparative Study of Degarelix Three-month Depot in Three Different Dosing Regimens in Patients With Prostate CancerNCT00116753 · 2005-01-01 · 1 site observation
COMPLETED
Efficacy and Safety of Prandial Inhalation of Technosphere/Insulin in Combination With Metformin or Technosphere/Insulin Alone Versus 2 Oral Anti-Diabetic Agents in Subjects With Type 2 DiabetesNCT00332488 · 2004-12-01 · 1 site observation
COMPLETED
Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy for Patients With Moderate HypertensionNCT00095550 · 2004-10-01 · 1 site observation
COMPLETED
Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy as First Line Treatment for Severe HypertensionNCT00095394 · 2004-09-01 · 1 site observation
COMPLETED
An Open Label Safety Study of Tipranavir Co-administered With Low-dose Ritonavir in Patients With Advanced HIV-1 Infection and Limited Treatment Options.NCT00933205 · 2004-05-01 · 1 site observation
APPROVED_FOR_MARKETING
A Parallel Group Comparison of the Efficacy and Safety of Degarelix at Two Different Dosing Regimens in Patients With Prostate CancerNCT00116779 · 2004-02-01 · 1 site observation
COMPLETED
Risedronate to Prevent Skeletal Related Events in Patients With Metastatic Prostate Cancer Commencing Hormonal TherapyNCT00216060 · 2003-10-01 · 1 site observation
TERMINATED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.